Marjorie Foo

1.0k total citations
24 papers, 652 citations indexed

About

Marjorie Foo is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marjorie Foo has authored 24 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marjorie Foo's work include Dialysis and Renal Disease Management (12 papers), Renal Diseases and Glomerulopathies (6 papers) and Renin-Angiotensin System Studies (5 papers). Marjorie Foo is often cited by papers focused on Dialysis and Renal Disease Management (12 papers), Renal Diseases and Glomerulopathies (6 papers) and Renin-Angiotensin System Studies (5 papers). Marjorie Foo collaborates with scholars based in Singapore, United Kingdom and Australia. Marjorie Foo's co-authors include Neil Boudville, David W. Johnson, Konstadina Griva, Augustine Kang, David Voss, Hemant Kulkarni, Tony Elias, Bernard F. Jones, Fiona G. Brown and Dwarakanathan Ranganathan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American Society of Nephrology and Quality of Life Research.

In The Last Decade

Marjorie Foo

22 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marjorie Foo Singapore 13 541 153 133 96 92 24 652
Moniek W.M. van de Luijtgaarden Netherlands 11 583 1.1× 134 0.9× 116 0.9× 130 1.4× 95 1.0× 13 764
Jianxiong Lin China 16 516 1.0× 105 0.7× 142 1.1× 73 0.8× 54 0.6× 60 766
Maristela Böhlke Brazil 15 465 0.9× 120 0.8× 192 1.4× 48 0.5× 62 0.7× 40 713
Helen Hurst United Kingdom 11 465 0.9× 137 0.9× 200 1.5× 83 0.9× 108 1.2× 35 580
Belkacem Issad France 16 485 0.9× 194 1.3× 158 1.2× 62 0.6× 92 1.0× 42 660
K. Farrington United Kingdom 11 527 1.0× 113 0.7× 62 0.5× 83 0.9× 166 1.8× 23 733
Paul Heidenheim Canada 12 376 0.7× 117 0.8× 133 1.0× 60 0.6× 41 0.4× 18 464
Andrea K. Viecelli Australia 15 269 0.5× 232 1.5× 156 1.2× 71 0.7× 214 2.3× 87 782
W E Bloembergen United States 9 596 1.1× 241 1.6× 188 1.4× 170 1.8× 100 1.1× 10 818
Christopher J. Deighan United Kingdom 10 405 0.7× 46 0.3× 143 1.1× 52 0.5× 61 0.7× 16 678

Countries citing papers authored by Marjorie Foo

Since Specialization
Citations

This map shows the geographic impact of Marjorie Foo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marjorie Foo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marjorie Foo more than expected).

Fields of papers citing papers by Marjorie Foo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marjorie Foo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marjorie Foo. The network helps show where Marjorie Foo may publish in the future.

Co-authorship network of co-authors of Marjorie Foo

This figure shows the co-authorship network connecting the top 25 collaborators of Marjorie Foo. A scholar is included among the top collaborators of Marjorie Foo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marjorie Foo. Marjorie Foo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Htay, Htay, et al.. (2021). Preliminary safety study of the Automated Wearable Artificial Kidney (AWAK) in Peritoneal Dialysis patients. Peritoneal Dialysis International. 42(4). 394–402. 14 indexed citations
2.
Foo, Marjorie, et al.. (2021). Thirty Days of Maintenance Peritoneal Dialysis Using a Sorbent-Based Automated Wearable Artificial Kidney (AWAK) PD Device in a Porcine Model. Journal of the American Society of Nephrology. 32(10S). 326–326.
3.
Woo, Keng Thye, Choong Meng Chan, Cynthia Ciwei Lim, et al.. (2020). The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two Decades. SHILAP Revista de lepidopterología. 6(4). 284–298. 4 indexed citations
4.
Finkelstein, Fredric O. & Marjorie Foo. (2020). Health-related quality of life and adequacy of dialysis for the individual maintained on peritoneal dialysis. Peritoneal Dialysis International. 40(3). 270–273. 10 indexed citations
5.
Brown, Edwina A., Peter G. Blake, Neil Boudville, et al.. (2020). International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Peritoneal Dialysis International. 40(3). 244–253. 169 indexed citations
6.
Lim, Cynthia Ciwei, et al.. (2019). Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia. International Urology and Nephrology. 51(6). 995–1004. 13 indexed citations
7.
Woo, Keng Thye, Choong Meng Chan, Cynthia Ciwei Lim, et al.. (2019). A Global Evolutionary Trend of the Frequency of Primary Glomerulonephritis over the Past Four Decades. Kidney Diseases. 5(4). 247–258. 27 indexed citations
8.
Kang, Augustine, et al.. (2019). Evaluating Burden and Quality of Life among Caregivers of Patients Receiving Peritoneal Dialysis. Peritoneal Dialysis International. 39(2). 176–180. 33 indexed citations
9.
10.
Woo, Keng-Thye, Kok‐Seng Wong, Marjorie Foo, et al.. (2014). Aliskiren and losartan trial in non-diabetic chronic kidney disease. Journal of the Renin-Angiotensin-Aldosterone System. 15(4). 515–522. 15 indexed citations
11.
Griva, Konstadina, Augustine Kang, Nandakumar Mooppil, et al.. (2013). Quality of life and emotional distress between patients on peritoneal dialysis versus community-based hemodialysis. Quality of Life Research. 23(1). 57–66. 54 indexed citations
12.
Woo, Keng-Thye, et al.. (2013). A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.. PubMed. 2(4). 129–35. 1 indexed citations
13.
Johnson, David W., Fiona G. Brown, Margaret Clarke, et al.. (2012). Effects of Biocompatible versus Standard Fluid on Peritoneal Dialysis Outcomes. Journal of the American Society of Nephrology. 23(6). 1097–1107. 125 indexed citations
14.
Johnson, David W., Fiona G. Brown, Margaret Clarke, et al.. (2012). The Effects of Biocompatible Compared with Standard Peritoneal Dialysis Solutions on Peritonitis Microbiology, Treatment, and Outcomes: The Balanz Trial. Peritoneal Dialysis International. 32(5). 497–506. 47 indexed citations
15.
Tan, Ru Yu, et al.. (2012). Dermatitis Secondary to Hypersensitivity to Icodextrin is a Rare Complication of Icodextrin Therapy in Peritoneal Dialysis. SHILAP Revista de lepidopterología. 21(2). 151–152.
16.
Woo, Keng-Thye, Marjorie Foo, Anantharaman Vathsala, et al.. (2010). Global Evolutionary Trend of the Prevalence of Primary Glomerulonephritis over the Past Three Decades. Nephron Clinical Practice. 116(4). c337–c346. 49 indexed citations
17.
Woo, Keng Thye, H. K. Tan, Marjorie Foo, et al.. (2009). Beneficial effects of high-dose losartan in IgA nephritis. Clinical Nephrology. 71(6). 617–624. 27 indexed citations
18.
Woo, Keng-Thye, Marjorie Foo, Evan J.C. Lee, et al.. (2008). High dose Losartan and ACE gene polymorphism in IgA nephritis. PubMed. 2(3-4). 83–91. 7 indexed citations
19.
Foo, Marjorie, et al.. (1998). Effect of salt-loading on blood pressure, insulin sensitivity and limb blood flow in normal subjects. Clinical Science. 95(2). 157–164. 28 indexed citations
20.
Foo, Marjorie, et al.. (1998). Effect of salt-loading on blood pressure, insulin sensitivity and limb blood flow in normal subjects. Clinical Science. 95(2). 157–157. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moniek W.M. van de Luijtgaarden Breakdown of academic impact, for papers by Jianxiong Lin Breakdown of academic impact, for papers by Maristela Böhlke Breakdown of academic impact, for papers by Helen Hurst Breakdown of academic impact, for papers by Belkacem Issad Breakdown of academic impact, for papers by K. Farrington Breakdown of academic impact, for papers by Paul Heidenheim Breakdown of academic impact, for papers by Andrea K. Viecelli Breakdown of academic impact, for papers by W E Bloembergen Breakdown of academic impact, for papers by Christopher J. Deighan
Rankless by CCL
2026